Finance

Lists
BAYRY:OTCMKTS
Bayer AG
12,64 $
-0,71%
(-0,090) 1D
12,64 $
0,00% (0,00)
After hours
Closed: 2 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BAYRY...
Open
12,87 $
High
12,87 $
Low
12,59 $
Mkt. cap
49,68 млрд
Avg. vol.
411,48 м.
Volume
669,15 м.
Dividend
0,25%
Quarterly dividend
0,01 $
Ex-dividend date
2026 ж. 27 сәу.
52-wk high
15,23 $
52-wk low
7,48 $
EPS
-0,50 $
Beta
0,57
Shares outstanding
3,93 млрд
No. of employees
88 мың
Open
12,87 $
High
12,87 $
Low
12,59 $
Mkt. cap
49,68 млрд
Avg. vol.
411,48 м.
Volume
669,15 м.
Dividend
0,25%
Quarterly dividend
0,01 $
Ex-dividend date
2026 ж. 27 сәу.
52-wk high
15,23 $
52-wk low
7,48 $
EPS
-0,50 $
Beta
0,57
Shares outstanding
3,93 млрд
No. of employees
88 мың
News stories
From web sources and news partners
Profile
Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index. Bayer was founded in 1863 in Barmen as a partnership between dye salesman Friedrich Bayer and dyer Johann Friedrich Weskott. The company was established as a dyestuffs producer, but the versatility of aniline chemistry led Bayer to expand its business into other areas. In 1899, Bayer launched the compound acetylsalicylic acid under the trademarked name Aspirin. Aspirin is on the World Health Organization's List of Essential Medicines. In 2021, it was the 34th most commonly prescribed medication in the United States, with more than 17 million prescriptions. In 1904, Bayer received a trademark for the "Bayer Cross" logo, which was, from 1910, subsequently stamped onto each aspirin tablet, creating an enduring brand image. Wikipedia
About Bayer AG
CEOBill Anderson
Employees87,8 мың
Founded1863 ж. 01 там.
Headquarters-
SectorPharmaceutical industry
Websitebayer.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
9,66 млрд
11,44 млрд
13,40 млрд
10,87 млрд
Cost of goods sold
4,31 млрд
4,23 млрд
5,23 млрд
4,52 млрд
Cost of revenue
4,31 млрд
4,23 млрд
5,23 млрд
4,52 млрд
Research and development expenses
1,50 млрд
1,29 млрд
1,42 млрд
1,51 млрд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,40 млрд
5,37 млрд
3,70 млрд
3,94 млрд
Operating expense
5,90 млрд
3,89 млрд
4,64 млрд
5,35 млрд
Total operating expenses
10,20 млрд
8,12 млрд
9,88 млрд
9,87 млрд
Operating income
-543,00 млн
3,32 млрд
3,53 млрд
999,00 млн
Other non operating income
-7,00 млн
1,51 млрд
-55,00 млн
-329,00 млн
EBT including unusual items
-1,16 млрд
-3,37 млрд
2,99 млрд
321,00 млн
EBT excluding unusual items
-1,16 млрд
4,63 млрд
2,99 млрд
502,00 млн
Income tax expense
-202,00 млн
378,00 млн
222,00 млн
92,00 млн
Effective tax rate
17,40%
-11,21%
7,43%
28,66%
Other operating expenses
993,00 млн
-2,76 млрд
-470,00 млн
-97,00 млн
Net income
-963,00 млн
-3,76 млрд
2,76 млрд
219,00 млн
Net profit margin
-9,97%
-32,85%
20,61%
2,01%
Earnings per share
0,57
-
-
-
Interest and investment income
-
471,00 млн
-
-
Interest expense
-539,00 млн
-527,00 млн
-474,00 млн
-81,00 млн
Net interest expenses
-539,00 млн
-56,00 млн
-474,00 млн
-81,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
412,00 млн
4,72 млрд
4,76 млрд
2,16 млрд
Gain or loss from assets sale
-33,00 млн
-191,00 млн
-161,00 млн
-14,00 млн
AI content may include mistakes. Learn more
Google қолданбалары